Drug discovery and development in tuberculosis

In history, drugs are discovered using active ingredients from ancient remedies, but nowadays diseases are controlled at the molecular and physiological level. The healthy approach to new drug discovery also measures the reduction in the prolonged clinical development of new drugs. This involves details about pre-clinical and clinical tuberculosis testing. Antibiotics have become scarce due to multiple drug resistance, the main cause of tuberculosis. The discovery of a new drug uses the inactive bacteria to develop a new drug for tuberculosis. Mycobacterium is resistant to most antibiotics. To achieve the shortest duration of therapy, it is expected to destroy the mycobacterial subpopulation.

    Drug discovery and development in tuberculosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in